Results 191 to 200 of about 30,070 (260)

Isolated Neutropenia as a Sentinel of High-Risk Clonal Evolution: Acute Myeloid Leukemia With Myelodysplasia-Related Changes Harboring <i>TP53</i> Deletion via Isochromosome 17q and Deletion 20q Mimicking a Myeloproliferative Neoplasm. [PDF]

J Med Cases
Gutierrez CLD, Quero-Taggaoa AKH.
europepmc   +1 more source

Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm

HemaSphere, 2018
Steffen Koschmieder, Nicolas Chatain
doaj   +1 more source

The Causal Role of the Gut Microbiota-Plasma Metabolome Axis in Myeloproliferative Neoplasm Pathogenesis: A Mendelian Randomization and Mediation Analysis. [PDF]

Metabolites
Kan H, Zhang K, Mao A, Geng L.
europepmc   +1 more source

[Myeloproliferative neoplasm with a homozygous germline SH2B3 mutation: a case report and literature review]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang W, Li R, Tian J, Jiang LJ, Bai J, Gu YH, Wang YY, Su Y, Li YQ, Xue YM, Chen JM, Wei YP.   +11 more
europepmc   +1 more source

ZRSR2 loss causes aberrant splicing in JAK2^V617F-driven myeloproliferative neoplasm but is not sufficient to drive disease progression. [PDF]

Hemasphere
Zhang R, Straube J, Janardhanan Y, Haldar R, Cooper L, Hayes N, Laurore C, Kim CJ, Luskin MR, Lindsley RC, Stahl M, Mullally A, Marneth AE, Bywater M, Lane SW.   +14 more
europepmc   +1 more source

Are Myeloproliferative Neoplasms‐Unclassifiable Really Unclassifiable?

eJHaem
Giovanni Barosi, Vittorio Rosti, Robert P. Gale   +2 more
doaj   +1 more source

Pathways to myeloproliferative neoplasm presentation and time to diagnosis: results from a cross-sectional study. [PDF]

BJGP Open
Tarburn EL, Iversen L, Robertson C, McShane C, Duncombe A, McMullin MF, Harrison C, Mesa R, Anderson LA.   +8 more
europepmc   +1 more source

A Case of Myeloproliferative Neoplasm with Eosinophilia Associated with PCM1-JAK2 Rearrangement. [PDF]

Case Rep Oncol
Zhou W, Guo X, Liu Y, Hao Z, Chu S, Zhang L, Li L.   +6 more
europepmc   +1 more source

Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm. [PDF]

Leukemia
Chowdhury S, Shrivastva S, Singh A, Ansari F, Naseer S, Roy A.   +5 more
europepmc   +1 more source

Unraveling the impact of lysosomal dysfunction on myeloproliferative neoplasm. [PDF]

Cancer Med
Yoon H, Lee D, Song S, Koo B, Park J, Kim TK, Kim S, Kim S, Hong J, Byun JM, Shin DY, Kim I, Koh Y, Yoon SS.   +13 more
europepmc   +1 more source